Starting with FDA approval of Donga super antibiotic, the birth of global drugs is expected to be in earnest
Starting with FDA approval of Donga super antibiotic, the birth of global drugs is expected to be in earnest.
On June 23, according to industry sources, it was identified that Green Cross and LG Life Sciences smoothly finished phase III clinical trials of global new drug, and are stepping on sta...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
